MC
TMO icon

McMorgan & Co’s Thermo Fisher Scientific TMO Stock Holding History

McMorgan & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-873
Closed -$423K – 57
2025
Q3 		$423K Buy
873
+20
+2% +$9.31K 0.07% 56
2025
Q2 		$346K Buy
853
+30
+4% +$12.5K 0.05% 56
2025
Q1 		$410K Sell
823
-45
-5% -$24.4K 0.07% 56
2024
Q4 		$452K Sell
868
-25
-3% -$13.7K 0.07% 54
2024
Q3 		$552K Sell
893
-5
-0.6% -$2.96K 0.09% 57
2024
Q2 		$497K Sell
898
-180
-17% -$103K 0.08% 55
2024
Q1 		$627K Sell
1,078
-20
-2% -$11.2K 0.11% 51
2023
Q4 		$583K Hold
1,098
– – 0.1% 51
2023
Q3 		$556K Sell
1,098
-20
-2% -$10.7K 0.1% 50
2023
Q2 		$583K Sell
1,118
-10
-0.9% -$5.4K 0.11% 52
2023
Q1 		$650K Sell
1,128
-35
-3% -$19.7K 0.13% 51
2022
Q4 		$640K Buy
1,163
+5
+0.4% +$2.65K 0.14% 51
2022
Q3 		$587K Hold
1,158
– – 0.14% 51
2022
Q2 		$629K Sell
1,158
-30
-3% -$16.5K 0.14% 50
2022
Q1 		$702K Sell
1,188
-60
-5% -$34.5K 0.15% 52
2021
Q4 		$833K Buy
1,248
+275
+28% +$172K 0.15% 53
2021
Q3 		$556K Buy
+973
New +$534K 0.11% 54

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

McMorgan & Co's TMO Position: Q4 2025 in Review

McMorgan & Co sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 873 shares — an estimated $423K sold.

McMorgan & Co first reported a position in TMO in Q3 2021 and held it in 17 quarters. The position peaked at $833K in Q4 2021. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • McMorgan & Co reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • McMorgan & Co sold 873 Thermo Fisher Scientific shares in Q4 2025, an estimated $423K.
  • McMorgan & Co first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 17 quarters.
  • McMorgan & Co's Thermo Fisher Scientific position peaked at $833K in Q4 2021.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on McMorgan & Co's 13F filing for Q4 2025, filed 11 Feb 2026.